Hospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (32)

2024

  1. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  2. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

2023

  1. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15

  2. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  3. Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation

    Heart, Vol. 109, Núm. 18, pp. 1401-1406

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

  2. Prognostic value of 3D area strain in moderate or severe aortic regurgitation with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 805-807

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. A genetic risk score predicts recurrent events after myocardial infarction in young adults

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 623-631

  3. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

  4. Differences between cardiologists’ perceptions and clinical reality of the quality of anticoagulation with vitamin K antagonists in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 332-334

  5. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

  6. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 985-993

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Access to INR and times for prescribing direct oral anticoagulants in patients treated with vitamin K antagonists in cardiology clinics in Spain

    REC: CardioClinics, Vol. 54, Núm. 4, pp. 231-238

  3. Current status of anticoagulation in patients with breast cancer and atrial fibrillation

    Breast, Vol. 46, pp. 163-169

  4. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

    Gastroenterology, Vol. 157, Núm. 1, pp. 74-86.e15

  5. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy

    International Journal of Cardiovascular Imaging, Vol. 35, Núm. 6, pp. 1055-1065

2018

  1. The Role of Frailty in Acute Coronary Syndromes in the Elderly

    Gerontology, Vol. 64, Núm. 5, pp. 422-429

2016

  1. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 67, Núm. 23, pp. 2705-2715